## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and conclusions as presented in the supplied abstract
- **Shared manuscript claim summary** The authors report on current usages of AlphaFold2, drawing on examples from the Coronavirus Structural Task Force, and assert that the tool is highly accurate, useful for expression construct design, de novo protein design, and Cryo-EM interpretation, but limited by training data, conformational variability, fold flexibility, missing co-factors, posttranslational modifications, and multimeric complexes with oligonucleotides, and imperfect chemical geometry. They conclude that machine learning based fold prediction is a game changer for structural bioinformatics and experimentalists.
- **Visible evidence base** Abstract text only; no figures, tables, methods, or results sections provided
- **Missing materials affecting confidence** Full manuscript, figures, tables, methods, validation data, and specific examples from the Coronavirus Structural Task Force are not available. The abstract provides no quantitative metrics, case studies, or comparative analyses.

## Reviewer
- **Overall assessment** The abstract presents a broad, largely qualitative perspective on AlphaFold2's utility and limitations, grounded in the authors' practical experience. The claims are plausible and align with the general literature, but the abstract lacks specific evidence, quantitative support, and a clear methodological framework. As a result, the scientific case is not established from the supplied material alone. The piece reads more as an opinion or perspective than a primary research report, which may be appropriate for the intended venue but does not meet the standards of a Nature-style research contribution.
- **Who would be interested in the results, and why** Structural biologists, computational biologists, and experimentalists using Cryo-EM or X-ray crystallography would find the practical insights relevant. The discussion of AlphaFold2's limitations, particularly regarding conformational variability and missing co-factors, is of interest to those developing or applying predictive tools. The perspective may also appeal to method developers in machine learning applied to biology.
- **Major strengths** The abstract addresses a timely and highly relevant topic. It provides a balanced view, acknowledging both the transformative potential and the current limitations of AlphaFold2. The authors' direct experience in the Coronavirus Structural Task Force lends practical credibility. The writing is clear and accessible to a broad scientific audience.
- **Major Concerns** 
  - R1-M1
  - R1-M2
  - R1-M3
- **Minor Comments** 
  - R1-m1
  - R1-m2
  - R1-m3
- **Technical failings that need to be addressed before the case is established** The abstract provides no quantitative evidence, no specific examples with data, and no methodological detail. The claim that AlphaFold2 is a "game changer" is an opinion not supported by measurable outcomes. The limitations listed are asserted without demonstration or citation. Without the full manuscript, the technical basis for these claims cannot be evaluated.
- **Assessment against Nature-style criteria** 
  - Originality: The topic is current, but the abstract does not present novel findings or a new conceptual framework. It summarizes known capabilities and limitations, which limits originality.
  - Scientific importance: The subject is important, but the abstract does not provide new data or insights that advance the field beyond existing literature.
  - Interdisciplinary readership: The topic bridges machine learning, structural biology, and experimental methods, which could appeal to a broad audience. However, the abstract lacks depth to engage specialists.
  - Technical soundness: Not assessable from the abstract alone. No methods, validation, or quantitative results are provided.
  - Readability for nonspecialists: The abstract is well written and accessible, with minimal jargon, which is a positive aspect.
- **Recommendation posture** Currently not established from the provided evidence. The abstract may be suitable for a perspective or commentary piece, but it does not meet the evidentiary standards for a Nature-style research article. Supportive if the full manuscript provides substantial quantitative and methodological support, but this cannot be assumed from the abstract.

### Major Concerns

- **Concern ID** R1-M1
- **Severity** Major
- **Blocking** Yes
- **Axis** Evidence sufficiency
- **Claim pointer** The authors claim that AlphaFold2 "can be utilized for the design of expression constructs, de novo protein design and the interpretation of Cryo-EM data with an atomic model" and that it has "unprecedented accuracy."
- **Evidence pointer** Abstract; location not provided
- **Concern** The abstract asserts specific applications and high accuracy without providing any quantitative data, case studies, or comparative benchmarks. No examples from the Coronavirus Structural Task Force are described in detail, and no metrics such as RMSD, model confidence scores, or success rates are given.
- **Why it matters** These are strong, specific claims that require empirical support to be credible. Without evidence, the reader cannot assess the validity or generalizability of the stated applications. The claim of "unprecedented accuracy" is particularly consequential and needs direct comparison with prior methods.
- **Resolution test** Provide in the full manuscript specific examples with quantitative outcomes, such as successful expression construct designs, Cryo-EM model improvements, or accuracy comparisons against experimental structures. Include error bars or confidence measures where applicable.

- **Concern ID** R1-M2
- **Severity** Major
- **Blocking** Yes
- **Axis** Claim scope
- **Claim pointer** The authors state that AlphaFold2 methods "are limited by their training data and are of limited use to predict conformational variability and fold flexibility; they also lack co-factors, posttranslational modifications and multimeric complexes with oligonucleotides."
- **Evidence pointer** Abstract; location not provided
- **Concern** These limitations are presented as general facts, but the abstract does not specify the conditions under which they apply, the extent of the limitations, or any supporting data. For example, AlphaFold2 has been shown to handle some multimeric complexes, so the blanket statement may be overly broad.
- **Why it matters** Overgeneralized limitations could mislead readers about the tool's actual capabilities and may not reflect the current state of the field. Precision in stating limitations is essential for accurate scientific communication.
- **Resolution test** In the full manuscript, qualify each limitation with specific examples or systematic tests. For instance, show cases where conformational variability prediction fails, or where multimeric complexes are not handled, and discuss any exceptions.

- **Concern ID** R1-M3
- **Severity** Major
- **Blocking** Yes
- **Axis** Conclusion support
- **Claim pointer** The authors conclude that "machine learning based fold prediction are a game changer for structural bioinformatics and experimentalists alike, with exciting developments ahead."
- **Evidence pointer** Abstract; location not provided
- **Concern** This conclusion is an opinion statement without direct support from the abstract's content. While it may be a reasonable perspective, it is presented as a definitive outcome rather than a reasoned inference from presented data.
- **Why it matters** In a scientific report, conclusions should follow from evidence. An unsupported sweeping statement weakens the manuscript's credibility and may be seen as promotional rather than analytical.
- **Resolution test** In the full manuscript, ground this conclusion in specific results, such as documented improvements in experimental workflows, time savings, or novel discoveries enabled by AlphaFold2. Provide a balanced discussion of counterexamples or unresolved challenges.

### Minor Comments

- **Concern ID** R1-m1
- **Severity** Minor
- **Axis** Clarity
- **Affected element** Terminology
- **Evidence pointer** Abstract; location not provided
- **Issue** The phrase "machine learning based fold prediction are a game changer" contains a subject-verb agreement error ("prediction are" should be "prediction is").
- **Required correction** Revise to "machine learning based fold prediction is a game changer" for grammatical correctness.

- **Concern ID** R1-m2
- **Severity** Minor
- **Axis** Scope definition
- **Affected element** Introduction of scope
- **Evidence pointer** Abstract; location not provided
- **Issue** The abstract states "we report on the current usages of this new tool" but does not define the scope of "current usages" or the time frame considered. It is unclear whether this is a systematic review, a personal perspective, or a case-based report.
- **Required correction** Clarify the scope and methodology in the abstract, such as stating whether this is a review of published literature, a survey of community practices, or a report of the authors' own experiences.

- **Concern ID** R1-m3
- **Severity** Minor
- **Axis** Completeness
- **Affected element** Reference to examples
- **Evidence pointer** Abstract; location not provided
- **Issue** The abstract mentions "examples from our work in the Coronavirus Structural Task Force" but provides no indication of what these examples demonstrate or how they are selected.
- **Required correction** Briefly describe the nature of these examples in the abstract, or ensure the full manuscript clearly contextualizes them within the claims made.

## Risk / unsupported claims
- The claim of "unprecedented accuracy" is unsupported without quantitative comparison data.
- The specific applications (expression construct design, de novo protein design, Cryo-EM interpretation) are asserted without demonstrated outcomes.
- The listed limitations (conformational variability, fold flexibility, missing co-factors, posttranslational modifications, multimeric complexes with oligonucleotides) are stated as general facts without evidence or qualification.
- The conclusion that AlphaFold2 is a "game changer" is an opinion not derived from presented data.
- The overall utility and impact of AlphaFold2 cannot be assessed from the abstract alone; the full manuscript is required for any substantive evaluation.